Somatropin is contraindicated in patients with Lively malignancy. For the reason that growth hormone deficiency could be a signal of pituitary or other brain tumors, the presence of this kind of tumors should be dominated out before treatment is initiated.Therefore caution really should be exercised when somatropin containing products and solutions